JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB258780

Human ALDH9A1 knockout HEK-293T cell lysate

Be the first to review this product! Submit a review

|

(0 Publication)

ALDH9A1 KO cell lysate available now. KO validated. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, Homozygous: 1 bp insertion in exon 1.
1 Images
Sanger Sequencing - Human ALDH9A1 knockout HEK-293T cell lysate (AB258780)
  • Sanger seq

Unknown

Sanger Sequencing - Human ALDH9A1 knockout HEK-293T cell lysate (AB258780)

Homozygous : 1 bp insertion in exon 1

Key facts

Cell type

HEK-293T

Species or organism

Human

Tissue

Kidney

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, Homozygous: 1 bp insertion in exon 1.

Product details

Knockout cell lysate achieved by CRISPR/Cas9.

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.

User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1Kit": { "sellingSize": "1 Kit", "publicAssetCode":"ab258780-1Kit", "assetComponentDetails": [ { "size":"1 x 100 µg", "name":"Human ALDH9A1 knockout HEK293T cell lysate", "number":"AB258780-CMP01", "productcode":"" }, { "size":"1 x 100 µg", "name":"Human wild-type HEK293T cell lysate", "number":"AB258780-CMP02", "productcode":"" } ] } } }

Properties and storage information

Gene name
ALDH9A1
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Zygosity
Homozygous
Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

ALDH9A1 also known as aldehyde dehydrogenase 9 family member A1 is an enzyme with a molecular mass of approximately 56 kDa. It catalyzes the conversion of aldehydes to carboxylic acids using NAD+ as a cofactor. ALDH9A1 is found in various tissues including the liver brain and kidney where it plays a role in the detoxification processes and metabolism of aldehydes which can be toxic to cells if not properly managed.
Biological function summary

Aldehyde dehydrogenase 9 family member A1 contributes to cellular homeostasis and plays a protective role by processing aldehydes derived from alcohol metabolism and lipid peroxidation. It forms part of the larger aldehyde dehydrogenase family but it does not appear to engage in complex formations with other proteins in any significant manner. ALDH9A1 also assists in the degradation of histidine and proline amino acids that require processing for proper cellular function.

Pathways

ALDH9A1 is significantly involved in the metabolic pathways of amino acids and fatty acids. In these pathways it is closely related to other aldehyde dehydrogenase proteins like ALDH2 which is active in metabolizing acetaldehyde within the alcohol metabolism pathway. Both ALDH9A1 and these proteins help maintain the balance of aldehyde concentrations ensuring no cellular damage occurs due to aldehyde accumulation.

ALDH9A1 has been implicated in neurological conditions such as Parkinson's disease due to its role in preventing aldehyde-induced oxidative stress. Additionally ALDH9A1 may be relevant to certain types of cancers where aldehyde metabolism disrupts normal cellular functions. Interestingly its relation to these diseases often connects it to proteins like ALDH2 which has similar detoxification roles. Understanding its interactions and contributions in these contexts remains an ongoing area of research.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com